Dr. Lechner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2020 Santa Monica Blvd
Ste 550
Santa Monica, CA 90404Phone+1 310-825-7922
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2018 - 2020
- Brigham and Women's HospitalResidency, Internal Medicine, 2014 - 2018
- Keck School of Medicine of the University of Southern CaliforniaClass of 2014
Certifications & Licensure
- CA State Medical License 2018 - 2026
- MA State Medical License 2017 - 2020
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Inductee Alpha Omega Alpha Honor Medical Society
Publications & Presentations
PubMed
- 4 citationsThe Combined Effect of Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors on Thyroid Function.Karen Tsai, Huiyan Ma, Tom Z Liang, Yan Xing, Samuel Chung
Thyroid. 2024-02-01 - 2 citationsSafety and efficacy of immune checkpoint inhibitor cancer therapy in patients with preexisting type 1 diabetes mellitus.Robin Hilder, Karen Tsai, Zoe Quandt, Dayna Isaacs, Alexandra Drakaki
Frontiers in Endocrinology. 2023-01-01 - 15 citationsInhibition of IL-17A Protects against Thyroid Immune-Related Adverse Events while Preserving Checkpoint Inhibitor Antitumor Efficacy.Melissa G Lechner, Mandy I Cheng, Anushi Y Patel, Aline T Hoang, Natalie Yakobian
Journal of Immunology. 2022-08-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: